Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

IACH Focus on Leukemia 2020 | The successes of the IACH meeting

Didier Blaise • 2 Oct 2020

IACH Focus on Leukemia 2020

General

Didier Blaise, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the successes of the International Academy for Clinical Hematology (IACH) meetings. The meeting enables researchers to bring their own experiences to the table and discuss research that is waiting for publication. It allows doctors to propose new developments and innovations to their patients. This interview took place during the 2020 Annual Meeting of the International Academy for Clinical Hematology (IACH).

Disclosures

Meeting registration, travels and accommodations funded by pharmaceutical companies: Jazz Pharmaceuticals, Sanofi, Pierre Fabre medicaments, Molmed
Personal or familial shares in the capital of pharmaceutical companies: None
Personal fees from pharmaceutical companies: Molmed

Allo-SCT in older patients with MDS: selection, donors, and timing

Didier Blaise • 4 Apr 2024

Chronological age no longer dictates eligibility for allogeneic transplantation in patients with MDS

Didier Blaise • 4 Apr 2024

Optimizing donor selection & conditioning regimens for patients with MDS receiving alloSCT

Didier Blaise • 4 Apr 2024

The challenge of age in SCT & cellular therapy, and introducing cellular therapy in earlier LOT

Didier Blaise • 24 Apr 2023

Related Videos

The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024

Natacha Bolaños • 16 Apr 2024

Distinguishing late-onset neutropenia from classical primary neutropenia

Carlo Dufour • 15 Apr 2024

The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract

James Ferrara • 16 Apr 2024

The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives

Claire Horgan • 15 Apr 2024